Publication | Closed Access

Treatment of queens in estrus and after estrus with a GnRH-agonist implant containing 4.7 mg deslorelin; hormonal response, duration of efficacy, and reversibility

Hormonal ContraceptiveHormonal ReceptorHormonal ResponseGynecologyAromataseDermatologyGnrh-agonist ImplantEndocrinologyMedicineMg DeslorelinOvarian HormoneReproductive Endocrinology